This site is intended for healthcare professionals only
LoginRegister
OverviewAuthored by Reviewed by References
Bisosafe 5

Medicine composition:
Bisoprolol
Marketed by:
Abbott India Ltd.
Manufactured By :
Abbott India Ltd.
Medicine Type :
Allopathy
Prescription Type :
Prescription Required
Approval :
DCGI (Drugs Controller General of India)
Pharmacological Class :
Beta-Blocker,
Therapy Class:
Antihypertensive,
Schedule :
Schedule H

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019982s014lbl.pdf

https://www.medicines.org.uk/emc/product/6126/pil#gref

https://go.drugbank.com/drugs/DB00612

Leopold G. Balanced pharmacokinetics and metabolism of bisoprolol. Journal of cardiovascular pharmacology. 1986 Jan 1;8:S16-20.

Willenheimer, R., van Veldhuisen, et.al. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation, 2005 112(16), pp.2426-2435.

undefined
Dr. Mahalakshmi Sivashankaran
Dr. Mahalakshmi Sivashankaran joined Medical Dialogues as an Intern in 2023. She is a BDS graduate from Manipal College of Dental Sciences, Mangalore Batch 2022, and worked as a Junior Resident at VMMC & Safdarjung Hospital at the Department of Dental Surgery till January 2023. She has completed a Diploma in Executive Healthcare management from the Loyola Institute of Business Administration, developing skills in Healthcare Management and Administration. She covers several medical specialties including Dental, ENT, Diagnostics, Pharmacology, Neurology, and Cardiology.
undefined
Dr JUHI SINGLA
Dr JUHI SINGLA has completed her MBBS from Era’s Lucknow Medical college and done MD pharmacology from SGT UNIVERSITY Gurgaon. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Page Created On:   3 May 2023 9:53 AM GMT
Page Last Updated On:   2023-05-05 06:48:50.0
X